Schedule 13G ownership disclosure

Abeona Therapeutics Inc

Common Stock, $0.01 par value · CUSIP: 00289Y206

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Suvretta Capital Management, LLC

    Shares: 2,676,000.00 · Class: 5.2%

  • Averill Master Fund, Ltd.

    Shares: 2,309,267.00 · Class: 4.5%

  • Aaron Cowen

    Shares: 2,676,000.00 · Class: 5.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-25-004720
Form type
SCHEDULE 13G/A
Filer
ABEONA THERAPEUTICS INC.
CIK
CIK 318306
Filed
Aug 13, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub